Aerosol pulmonary immune engineering

Sudduth, Emma R.; Trautmann-Rodriguez, Michael; Gill, Nicole L.; Bomb, Kartik; Fromen, Catherine A.

doi:10.1016/j.addr.2023.114831

Cited by 17 publications

(1 citation statement)

References 359 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Atomized drugs are a user-friendly means of administering medication and could maintain efficacious concentrations of drugs at different sites in the lung, allowing the drug to penetrate readily through the lung mucosa to the blood supply ( 27 ). Aerosolization of immunotherapeutic agents has potential to manipulate the local mucosal-specific microenvironment ( 28 ). Compared with intratracheal administration, the delivery of drugs via a mucosal atomization device could be more likely to achieve therapeutic concentrations with pharmacokinetic effect ( 29 ).…”

Section: Introductionmentioning

confidence: 99%

Secretome of EMSCs neutralizes LPS‑induced acute lung injury via aerosol administration

Tan,

Zhuo,

Wang

et al. 2023

Int J Mol Med

View full text Add to dashboard Cite

Ectodermal mesenchymal stem cells (EMSCs) are cells harvested from the stem cell niche (nasal mucosa) with high therapeutic potential. To the best of our knowledge, however, the anti-inflammatory properties of these neural crest-derived EMSCs have been rarely reported. The present study aimed to explore the effects of aerosolized EMSC-Secretome (EMSC-Sec) and clarify underlying mechanisms in treating acute lung injury (ALI). EMSCs were isolated by adherent method and identified by immunofluorescence staining. EMSC-Sec was collected and evaluated using western blotting, BCA and ELISA tests. Then, mouse lung epithelial cells (MLE-12) were used to mimic inflammatory stimulation with lipopolysaccharide (LPS). After developing an ALI model through intraperitoneal injection of LPS, mice were treated with an EMSC-Sec spray. The lung in each group underwent an observation and measurement to preliminarily assess the extent of damage. H&E staining, immunohistochemical staining, immunofluorescence and western-blotting were utilized to further access the impacts of EMSC-Sec. The results showed that EMSC-Sec had great anti-inflammatory potential and was highly successful in vitro and in vivo . EMSC-Sec mitigated LPS-induced ALI with low inflammatory cell inflation and mild damage. EMSC-Sec could regulate inflammation via the NF-κB(p50/p65)/NLRP3 pathway. Overall, the present study demonstrated that EMSC-Sec regulated inflammation, hoping to provide a novel strategy for ALI treatment.

show abstract

Section: Introductionmentioning

confidence: 99%